Eitan Hoch

Background

About Eitan Hoch

Innovative and results-driven scientist with a strong track record in drug discovery, cell biology, in vitro pharmacology, and assay development. Adept at translating complex biological insights into actionable therapeutic strategies. Demonstrated success in identifying and validating novel therapeutic targets, and in developing and optimizing cell-based assays to advance small-molecule programs from early discovery through preclinical development. Therapeutic area experience includes type 2 diabetes, hepatobiliary and renal diseases, and rare genetic disorders. Experienced in leading internal scientific teams and cross-functional project groups, as well as managing external collaborations and CROs. Adept at setting scientific vision, aligning priorities with organizational goals, and delivering results in dynamic, matrixed environments. Currently exploring new opportunities at the Principal Scientist to Director level in drug discovery. I’m particularly interested in roles where I can contribute to early discovery, platform development, and hit-to-lead strategy — leveraging scientific innovation to build and advance robust discovery pipelines, lead high-performing teams, and collaborate cross-functionally to deliver transformative therapeutics to patients